Private Trust Company’s Halozyme HALO Stock Holding History

Private Trust Company’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25K	Hold	16	–	–	﹤0.01%	2568
2026 Q1	$1.03K	Hold	16	–	–	﹤0.01%	2475
2025 Q4	$1.08K	Sell	16 -8	-33%	-$538	﹤0.01%	2415
2025 Q3	$1.76K	Sell	24 -33	-58%	-$2.19K	﹤0.01%	2363
2025 Q2	$2.94K	Sell	57 -8	-12%	-$455	﹤0.01%	2193
2025 Q1	$4.15K	Sell	65 -15	-19%	-$871	﹤0.01%	2092
2024 Q4	$3.83K	Hold	80	–	–	﹤0.01%	2075
2024 Q3	$4.58K	Sell	80 -20	-20%	-$1.15K	﹤0.01%	1978
2024 Q2	$5.24K	Hold	100	–	–	﹤0.01%	1910
2024 Q1	$4.07K	Sell	100 -18	-15%	-$675	﹤0.01%	1982
2023 Q4	$4.36K	Sell	118 -45	-28%	-$1.7K	﹤0.01%	1978
2023 Q3	$6.23K	Hold	163	–	–	﹤0.01%	1791
2023 Q2	$5.88K	Sell	163 -26	-14%	-$887	﹤0.01%	1826
2023 Q1	$7.22K	Buy	189 +18	+11%	+$844	﹤0.01%	1710
2022 Q4	$10K	Sell	171 -9	-5%	-$461	﹤0.01%	1546
2022 Q3	$7K	Sell	180 -10	-5%	-$442	﹤0.01%	1569
2022 Q2	$8K	Buy	+190	New	+$8.22K	﹤0.01%	1582

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Private Trust Company's HALO Position: Q2 2026 in Review

Private Trust Company held its Halozyme (HALO) position steady in Q2 2026 at 16 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

Private Trust Company first reported a position in HALO in Q2 2022 and has held it in 17 quarters since. The position peaked at $10K in Q4 2022. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Private Trust Company held 16 shares of Halozyme worth $1.25K as of Q2 2026.
Private Trust Company left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2568 holding.
Private Trust Company first reported a position in Halozyme in Q2 2022 and has held it in 17 quarters since.
Private Trust Company's Halozyme position peaked at $10K in Q4 2022.
674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.